Avrok has over 100 years of combined experience in oncology research and diagnostics, focussing on early stage detection and classification of tumors. Avrok has experience in rapid development of novel assays in oncology, going from feasibility to validation in a little as 3-6 months.
liquid biopsy
Cell-Free DNA/RNA
Circulating Tumor Cells
tumor typing
Profile 500+ unique genes for single gene and multiple gene biomarker insights.
Single gene biomarkers from all variant types including SNVs, indels, CNVs, known and novel fusions, and splice variants.